Home|Journals|Articles by Year|Audio Abstracts
 

Original Research



CYTOTOXIC, BIOCHEMICAL AND ANTITUMOR ACTIVITY OF CAMEL URINE ON EHRLICH ASCITES CARCINOMA CELL-BEARING SWISS ALBINO MICE.

S.S. Al-Rejaie, A.M. Aleisa, S.A. Bakheet, M.M. Al-Harbi, A.M. Al-Bekairi, O.A. Al-Shabanah, Abdulhakeem Al-Majed, Abdulaziz A.Al-Yayha, S. Qureshi.




Abstract

The cytotoxic, biochemical and anti- tumor properties of Camel urine (CU) were evaluated in Ehrlich ascites carcinoma (EAC) cell-bearing mice. the anti-tumor activity of CU was evaluated on the bases of cytotoxicity and viability of EAC and their nucleic acid, protein, malondialdehyde and glutathione concentrations in addition to observations on survival of treated animals. tumors grown at the site of inoculation were evaluated for histopathological changes. The results obtained in EAC cell-bearing mice revealed the cytotoxic, biochemical and anti-tumor activity of CU to be close to that of the provency to toxic drug Cyclophosphamide (CP). Our results on the cytotoxicity and viability of some of the known constituents of CU (creatinine, adenine, and urea) revealed creatinine to be highly cytotoxic. The anti-tumor activity observed in the present study may be due to creatinine as one of the cytotoxic constituents of CU. The cytotoxic and antioxidative potentials of CU observed in the present study warrant further investigation on the active constituents of CU and their mode of action and safety before any consideration for clinical trials.

Key words: Camel urine, EAC cells, Cytotoxicity, Biochemical changes, Histopathology.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.